(Q33858435)

29 July 2017

1 reference

title

Angiogenic growth factor expression in placenta (English)

1 reference

29 July 2017

Smith SK

1

1 reference

29 July 2017

He Y

series ordinal

2

1 reference

29 July 2017

Clark DE

series ordinal

3

1 reference

29 July 2017

Charnock-Jones DS

series ordinal

4

1 reference

29 July 2017

publication date

1 February 2000

1 reference

29 July 2017

published in

Seminars in Perinatology

1 reference

29 July 2017

volume

24

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

82-86

1 reference

Mechanisms of angiogenesis

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980063-4

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980063-4

7 January 2021

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980063-4

7 January 2021

Molecular cloning of a novel vascular endothelial growth factor, VEGF-D

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980063-4

7 January 2021

Neuropilin-1 is a placenta growth factor-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980063-4

7 January 2021

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980063-4

7 January 2021

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980063-4

7 January 2021

Expression of mRNA for vascular endothelial growth factor in human placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980063-4

7 January 2021

Localization of VEGF and expression of its receptors flit and KDR in human placenta throughout pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980063-4

7 January 2021

A Vascular Endothelial Growth Factor Antagonist Is Produced by the Human Placenta and Released into the Maternal Circulation1

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980063-4

7 January 2021

Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980063-4

7 January 2021

Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980063-4

7 January 2021

Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980063-4

7 January 2021

Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980063-4

7 January 2021

Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980063-4

7 January 2021

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2800%2980063-4

7 January 2021

10.1016/S0146-0005(00)80063-4

Identifiers

DOI

1 reference

29 July 2017

1 reference